HomeMOL › Filing
🔔 Get instant alerts when MOL files quarterly results on BSE Start free trial →

Investor presentation

Filed: 29 Jul 2026, 13:43 IST Exchange: BSE Category: Financial Results — Investor Presentation
AI summary - Q1 FY27 standalone revenue 523 Cr, down 12% YoY; EBITDA 94 Cr, up 16% YoY; margin 17.9% - Crop Protection revenue 392 Cr, EBITDA 78 Cr, margin 19.9%; production down 17%, utilization 63% - Pigments revenue 131 Cr, EBITDA 16 Cr, margin 12.1%; production down 14%, utilization 39% - Softer demand and macro uncertainties impacted volumes; better pricing and mix improved margins - Consolidated Q1 FY27 PAT rose 280% YoY to 48 Cr; EBITDA margin improved to 18% - Scheme to amalgamate subsidiaries KCL and MCNL with MOL approved by board and filed with NCLT - Capex underway for growth and margin improvement targeting 14-15% blended EBITDA margin
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 MOL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add MOL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Meghmani Organics Limited

Important. The summary above is generated automatically from Meghmani Organics Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.